What are Mission Vision & Core Values of Galapagos Company?

Galapagos Bundle

Get Full Bundle:

	BCG	$15	$10
	5 FORCES	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

What are the Mission, Vision, and Core Values of the Company?

Mission and vision statements are crucial for any successful enterprise, providing strategic direction and fostering corporate identity. For biotechnology companies operating in the innovative biopharmaceutical sector, these statements are particularly vital. They guide strategic decisions, shape research and development, influence partnerships, and define corporate identity.

The company, headquartered in Mechelen, Belgium, focuses on discovering and developing innovative medicines for inflammatory, fibrotic diseases, and oncology. Their proprietary target discovery platform identifies novel drug candidates. As of April 2025, they are actively involved in various clinical programs, demonstrating their commitment to pioneering new treatments. Learn more about their strategic approach with the Galapagos BCG Matrix.

The Galapagos mission statement emphasizes a commitment to transforming patient lives through innovative medicines. This involves the discovery and development of novel treatments, particularly in areas with high unmet medical needs. The company aims to deliver life-changing science globally, driven by a relentless pursuit of groundbreaking science, an entrepreneurial spirit, and a collaborative mindset. This patient-centric and innovation-focused approach defines the Galapagos company purpose and goals.

Patient-Centric Innovation

Galapagos focuses on developing novel treatments to transform patient lives, addressing high unmet medical needs globally.

Groundbreaking Science

The company is dedicated to the relentless pursuit of scientific breakthroughs, investing significantly in research and development.

Entrepreneurial Spirit

An entrepreneurial mindset drives their approach to innovation, fostering agility and proactive problem-solving.

Collaborative Mindset

Collaboration is key to their strategy, enabling partnerships that accelerate the development of new therapies.

Global Reach

Galapagos aims to deliver life-changing science and innovation to patients across the globe.

Addressing Unmet Needs

A core focus is on therapeutic areas where current treatments are insufficient, providing significant patient benefit.

Galapagos NV's mission is to accelerate transformational innovation through the relentless pursuit of groundbreaking science, an entrepreneurial spirit, and a collaborative mindset. This commitment is evident in their financial allocations; in 2024, Galapagos reported R&D expenses of €335.5 million, with subcontracting costs increasing by €77.1 million, primarily driven by cell therapy programs in oncology. This reflects their dedication to groundbreaking science and addressing unmet medical needs. Their development of GLPG5101, a CD19 CAR-T candidate, which has shown compelling clinical data in relapsed/refractory non-Hodgkin lymphoma with a median vein-to-vein time of seven days, exemplifies their dedication to accelerating transformational innovation and delivering fresh, fit cells to patients. This rapid delivery system showcases their innovative and patient-first approach in business operations, aligning with the Galapagos mission statement and values. For more insights into the company's journey, explore a Brief History of Galapagos.

Galapagos SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The Galapagos vision statement emphasizes a commitment to global impact, aiming to extend and improve lives through scientific breakthroughs. This forward-looking vision drives the company's strategic decisions, including its focus on innovative therapies. The company's strategic re-evaluation in 2025, exploring options for its cell therapy business, underscores its dedication to maximizing resources for transformative business development, aligning with its ambitious vision for patient outcomes.

Galapagos Mission

Galapagos's mission is to discover, develop, and commercialize innovative medicines that address significant unmet medical needs. This mission guides their research and development efforts.

Patient Focus

A core aspect of Galapagos's mission is prioritizing patients, ensuring their scientific endeavors translate into tangible health benefits and improved quality of life.

Scientific Excellence

Galapagos is committed to scientific rigor and innovation, fostering a culture that pushes the boundaries of biotechnology to deliver groundbreaking therapies.

Collaboration

The company values strong partnerships and collaborations within the scientific community to accelerate drug discovery and development, enhancing its overall impact.

Integrity and Ethics

Galapagos maintains high ethical standards in all operations, ensuring transparency and responsibility in research, development, and business practices.

Innovation Drive

Innovation is central to Galapagos's core values, driving their pursuit of novel mechanisms of action and therapeutic approaches to address complex diseases.

Galapagos's mission statement focuses on discovering, developing, and commercializing innovative medicines to address significant unmet medical needs. This commitment is evident in their strategic initiatives, such as the exploration of new therapeutic areas and the optimization of their pipeline. The company's strong financial position, with approximately €3.1 billion in cash and financial investments as of June 30, 2025, supports its ability to invest in high-impact research and development. This financial strength, coupled with their strategic agility, as detailed in the Growth Strategy of Galapagos, positions them to achieve their mission of transforming patient outcomes globally.

Galapagos PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Galapagos company values are fundamental to its operations, guiding its strategic decisions and fostering a distinct corporate culture. These core values shape how the company approaches drug discovery, patient care, and internal collaboration.

We put patients first, always.

This core value ensures that patient well-being is at the forefront of all activities, from research to product development. The focus on diseases with high unmet medical needs, such as inflammatory and fibrotic diseases and oncology, exemplifies this commitment.

We innovate with open minds.

An open and curious mind fuels innovation at Galapagos, driving significant investment in research and development. In 2024, R&D expenses reached €335.5 million, a substantial increase from €241.3 million in 2023, reflecting a commitment to exploring new scientific frontiers.

We take ownership.

This value emphasizes accountability and responsibility for actions and results, particularly in the development and commercialization of proprietary products. The company's strategic re-evaluation to maximize resources for transformative business development showcases this ownership.

Together, we make it happen.

Collaboration and co-creation are central to this value, fostering teamwork internally and strategic partnerships externally. This includes collaborations like the one with Adaptimmune on the MAGE-A4 directed TCR T-cell therapy candidate uza-cel.

These Galapagos core values collectively define the company's identity and operational framework. Understanding these principles is key to grasping how the Galapagos mission and vision influence the company's strategic decisions. For more insights into the competitive landscape, explore the Competitors Landscape of Galapagos.

Galapagos Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

A company's mission and vision are foundational, guiding its strategic decisions and shaping its long-term trajectory. These statements articulate the company's purpose and its aspirations, influencing everything from product development to market entry.

Galapagos' Strategic Compass: Mission and Vision in Action

Galapagos NV's strategic decisions are intrinsically linked to its mission and vision, steering its focus towards transformative innovation and improved patient outcomes.

• The company's strategic direction is heavily influenced by its mission to accelerate transformational innovation.
• Its vision to transform patient outcomes underpins its pursuit of life-changing science.
• Recent strategic evaluations, including the consideration of a business separation in early 2025 and subsequent re-evaluation in May 2025, reflect an agile approach to maximizing resources for business development and advancing its cell therapy pipeline.
• The company's commitment to R&D, with €335.5 million invested in 2024, directly aligns with its mission of scientific advancement.
• Exploration of strategic alternatives for existing businesses, such as the potential divestiture of its cell therapy business announced in July 2025, demonstrates a commitment to shareholder value and pipeline enhancement.

Mission: Driving Transformational Innovation

Galapagos' mission centers on the relentless pursuit of groundbreaking science, aiming to deliver innovative treatments that significantly impact patient lives. This purpose fuels their investment in cutting-edge research and development, exemplified by their substantial R&D expenditure.

Vision: Transforming Patient Outcomes

The company's vision is to achieve life-changing science and innovation, ultimately transforming patient outcomes. This aspirational goal guides their focus on developing therapies for conditions with high unmet medical needs, such as their GLPG5101 program in oncology.

Core Values: Guiding Principles

While specific core values are not explicitly detailed in the provided information, the company's actions suggest a strong emphasis on scientific rigor, innovation, and a patient-centric approach. Their strategic maneuvers and investment priorities reflect a commitment to these underlying principles.

R&D Investment: A Testament to Mission

In 2024, Galapagos reported R&D expenses of €335.5 million, a significant allocation demonstrating their dedication to advancing their scientific pipeline, particularly in cell therapy programs for oncology.

Strategic Agility and Financial Strength

With a cash position of €3.1 billion as of June 30, 2025, Galapagos possesses the financial capacity to pursue transformational transactions and maximize resources for business development, aligning with their overarching mission and vision.

Focus on Transformational Transactions

The company's CEO, Henry Gosebruch, emphasized in July 2025 the priority to execute transformational transactions to build an innovative pipeline and maximize cash for business development, directly linking operational goals to their mission and vision.

Galapagos' mission and vision are integral to its strategic decision-making, influencing R&D investments and business development activities. Their focus on transformational innovation and patient outcomes guides their pursuit of groundbreaking science. Continue reading to explore core improvements to the company's mission and vision.

Galapagos Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Galapagos NV's mission and vision statements are foundational to its operations, guiding its pursuit of innovative medicines. Enhancements could focus on greater specificity regarding global health impacts and the integration of its unique technological capabilities.

Enhance Global Health Focus

Broadening the mission and vision to explicitly mention specific global health challenges or patient populations could amplify their impact and resonance.

Highlight Technological Differentiation

Directly incorporating references to proprietary platforms, like their target discovery and decentralized cell therapy manufacturing, would underscore their competitive edge.

Integrate Sustainability Commitment

Embedding a commitment to sustainability and responsible innovation into the core statements would present a more holistic corporate purpose, aligning with evolving industry expectations.

Refine for Adaptability and Clarity

Refining statements to be more explicit about their scientific approach and patient focus ensures clarity and adaptability in a dynamic biotechnology landscape.

The mission of Galapagos NV centers on discovering and developing transformative medicines for patients with severe diseases. Their vision is to bring these innovative treatments to patients worldwide, addressing significant unmet medical needs. The company's core values emphasize scientific excellence, entrepreneurial spirit, collaboration, and a patient-centric approach. These values underpin their strategy to advance a pipeline of novel therapies, particularly in areas like inflammation, fibrotic diseases, and oncology. Understanding the Revenue Streams & Business Model of Galapagos provides further context for how these mission, vision, and core values translate into tangible business operations and strategic decisions.